drug

AMG-513

1 story · latest Aug 4, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Amgen

Timeline

Amgen updates MariTide pipeline, discontinues AMG 513, keeps pressing FDA on TAVNEOS

Aug 4Quarterly updateAMG-513 Amgen

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.